HLA-DP antigens are involved in the susceptibility to multiple sclerosis. 1988

N Odum, and J J Hyldig-Nielsen, and N Morling, and M Sandberg-Wollheim, and P Platz, and A Svejgaard
Tissue Typing Laboratory, State University Hospital (Rigshospitalet) Copenhagen, Denmark.

Forty-five unrelated patients with multiple sclerosis (MS) from Sweden and 166 Danish controls were typed for HLA-DP using Primed Lymphocyte Typing. Thirty-nine MS-patients and 63 controls were also DNA-typed with the Restriction Fragment Length Polymorphism (RFLP) technique for HLA-DP and -DR genes. The frequencies of DPw4 were 93.3% in MS patients and 72.3% in controls (relative risk, RR = 5.4, p = 0.0014). The DR2 antigen was present in 75.5% of the patients and in 33.7% of the controls (RR = 6.1, p less than 10(-6)). DPw4 was not associated (i.e., was not in linkage disequilibrium) with DR2 in patients or controls. Thus, in MS the associations with DP and DR are independent of each other. However, the combined presence of DPw4 and DR2 gave a significantly higher risk than each antigen alone, indicating that synergism between DP and DR gene products may play a role in the genetic susceptibility to MS.

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006681 HLA-D Antigens Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology. Antigens, HLA-D,Class II Human Antigens,HLA-Dw Antigens,Human Class II Antigens,Ia-Like Antigens, Human,Immune Response-Associated Antigens, Human,Immune-Associated Antigens, Human,Immune-Response Antigens, Human,HLA-D,HLA-Dw,Immune Response Associated Antigens, Human,Antigens, HLA D,Antigens, HLA-Dw,Antigens, Human Ia-Like,Antigens, Human Immune-Associated,Antigens, Human Immune-Response,HLA D Antigens,HLA Dw Antigens,Human Ia-Like Antigens,Human Immune-Associated Antigens,Human Immune-Response Antigens,Ia Like Antigens, Human,Immune Associated Antigens, Human,Immune Response Antigens, Human
D006682 HLA-DP Antigens A group of the D-related HLA antigens (human) found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HLA-PL Antigens,HLA-SB Antigens,HLA-DP,HLA-PL,HLA-SB,Antigens, HLA-DP,Antigens, HLA-PL,Antigens, HLA-SB,HLA DP Antigens,HLA PL Antigens,HLA SB Antigens
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N Odum, and J J Hyldig-Nielsen, and N Morling, and M Sandberg-Wollheim, and P Platz, and A Svejgaard
August 1998, Tissue antigens,
N Odum, and J J Hyldig-Nielsen, and N Morling, and M Sandberg-Wollheim, and P Platz, and A Svejgaard
September 1980, Ceskoslovenska neurologie a neurochirurgie,
N Odum, and J J Hyldig-Nielsen, and N Morling, and M Sandberg-Wollheim, and P Platz, and A Svejgaard
June 1977, Journal of the neurological sciences,
N Odum, and J J Hyldig-Nielsen, and N Morling, and M Sandberg-Wollheim, and P Platz, and A Svejgaard
June 1976, Neurology,
N Odum, and J J Hyldig-Nielsen, and N Morling, and M Sandberg-Wollheim, and P Platz, and A Svejgaard
December 1977, Proceedings of the Royal Society of Medicine,
N Odum, and J J Hyldig-Nielsen, and N Morling, and M Sandberg-Wollheim, and P Platz, and A Svejgaard
September 1984, Tissue antigens,
N Odum, and J J Hyldig-Nielsen, and N Morling, and M Sandberg-Wollheim, and P Platz, and A Svejgaard
August 1990, Human immunology,
N Odum, and J J Hyldig-Nielsen, and N Morling, and M Sandberg-Wollheim, and P Platz, and A Svejgaard
January 1998, Human immunology,
N Odum, and J J Hyldig-Nielsen, and N Morling, and M Sandberg-Wollheim, and P Platz, and A Svejgaard
May 2019, Journal of neuroimmunology,
N Odum, and J J Hyldig-Nielsen, and N Morling, and M Sandberg-Wollheim, and P Platz, and A Svejgaard
August 1995, Annals of neurology,
Copied contents to your clipboard!